Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now

Zacks highlights positive Earnings ESP readings for AT&T and Broadcom ahead of their earnings reports: AT&T’s estimate is $0.63 per share versus a $0.61 consensus (+3.77%), and Broadcom’s is $3.89 versus $3.82 (+1.86%). Both stocks carry a Zacks Rank #3 (Hold), and the article says the metrics may signal positive earnings surprises; it reports no actual results or market reaction. Zacks also cites a backtest in which stocks with a #3 rank or better and positive ESP produced positive surprises 70% of the time and average annual returns of 28.3% over 10 years.

Analysis

The signal here is analyst-estimate dispersion, not new evidence of improving business fundamentals. A small positive revision gap can raise the odds of an EPS beat, but a beat is not necessarily a positive stock catalyst if investors are already positioned for it or management’s forward commentary disappoints. The cited backtest is promotional and, without details on fees, portfolio construction, exposure, and out-of-sample performance, is not a reliable standalone basis for sizing risk.

Treat AT&T and Broadcom differently: AT&T is a telecom operator, so labeling it a “Computer and Technology” screen result adds no useful sector information. Its near-term reaction should hinge on operating and cash-flow signals, not the EPS surprise alone. For Broadcom, the estimate signal is much farther from the event and can change materially; any read-through to semiconductor or AI-related sentiment depends on forward demand and guidance, not the current small revision gap.

Contrarian view: the article frames positive ESP as an exploitable edge, but the market may already incorporate the same revisions. The likely error is buying a binary event on a weak proxy. No fundamental trade is justified from this information alone; the actionable edge is to wait for verified revisions, expectations in options, and the quality of reported results. Near-term reversal risk is a headline beat accompanied by weak guidance or cash conversion; the 1–3 month catalyst is subsequent estimate revisions, while any 6–18 month thesis requires evidence of durable operating improvement.

Key Decisions for Investors

• Do not buy T or AVGO solely on the reported positive ESP. For T’s imminent report, stay flat into the release absent a demonstrable valuation or positioning edge; reassess after results against free-cash-flow conversion, subscriber trends, and guidance. A headline EPS beat with weaker cash flow or outlook falsifies the bullish read.
• Keep AVGO on a watchlist rather than trading the current estimate gap: the report is weeks away, leaving time for revisions and expectations to move. Recheck consensus revisions and options-implied earnings move closer to the event; avoid treating this as a confirmed AI or semiconductor demand signal.
• For either name, consider an event position only if independently verified estimate revisions persist and the expected move priced in options is attractive relative to the likely post-report range. Missing inputs are current implied volatility, positioning, and the underlying operating metrics; without them, there is no defined risk/reward.